AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Glanbia plc
Video analysis: GLAPY
All videosNo video analysis for this stock yet. Request one from our team.
News: GLAPY
Glanbia plc (GLAPY) Q2 2026 Earnings Call Transcript
Glanbia plc (GLAPY) Q2 2026 Earnings Call Transcript
Glanbia hikes profit forecast as weight-loss drugs boost demand for protein products
Nutrition supplement maker Glanbia hiked its full-year profit forecast on Thursday following bumper demand for its protein products, including from customers using them in tandem with weight-loss drugs.
Glanbia Stock More Than Doubles as Protein Demand May Rise 37%
Glanbia (GLAPY) shares have rallied sharply as investors continue to reward the Irish nutrition group's exposure to the booming demand for protein products. The
Similar companies
-
Conagra Brands, Inc.
CAG
·
New York Stock Exchange
Compare
-
Hengan International Group Company Limited
HEGIY
·
Other OTC
Compare
-
Jeronimo Martins, SGPS S.A. Unsponsored ADR
JRONY
·
Other OTC
Compare
-
The Kraft Heinz Company
KHC
·
NASDAQ
Compare
-
Kerry Group plc
KRYAY
·
Other OTC
Compare
-
Nestlé S.A.
NESN.SW
·
Swiss Exchange
Compare